Berg CD

No ORCID on file · 3 papers in corpus
2016
Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2016.08.334

BackgroundThe Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial originally reported no mortality benefit of ovarian cancer screening after a median of 12.4years of follow-up. The UKCTOCS screening trial failed to show a s…

2011
Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2010.11.015

ObjectiveIn the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO), ovarian cancer screening with transvaginal ultrasound (TVU) and CA-125 produced a large number of false-positive tests. We examined relationships between …

2011
Potential role of HE4 in multimodal screening for epithelial ovarian cancer.
Journal of the National Cancer Institute ·doi:10.1093/jnci/djr359

In screening for epithelial ovarian cancer, unnecessary surgery can be reduced by limiting use of transvaginal ultrasound (TVU) to women with increasing CA125 serum levels. Replacing or augmenting TVU with measurement of a serum marker spec…